A novel selective small-molecule PI3K inhibitor is effective against human multiple myeloma in vitro and in vivo

Developing effective therapies against multiple myeloma (MM) is an unresolved challenge. Phosphatidylinositol-3-kinase (PI3K) activation may be associated with tumor progression and drug resistance, and inhibiting PI3K can induce apoptosis in MM cells. Thus, targeting of PI3K is predicted to increas...

Descripción completa

Detalles Bibliográficos
Autores principales: Glauer, J, Pletz, N, Schön, M, Schneider, P, Liu, N, Ziegelbauer, K, Emmert, S, Wulf, G G, Schön, M P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789203/
https://www.ncbi.nlm.nih.gov/pubmed/24013662
http://dx.doi.org/10.1038/bcj.2013.37

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3789203/
https://www.ncbi.nlm.nih.gov/pubmed/24013662
http://dx.doi.org/10.1038/bcj.2013.37

Ejemplares similares